Ayala Pharmaceuticals Inc (ADXS)

[Easymoneyman00]

Cash on hand is worth $2.50 a share ! That means all of our patents and platform , manufacturing facility and partnerships are worth $1.50 ? Does that make any sense to any investor here? Take away our cash and we are worth $1.50 a share with everything that we have going? Phase 3 ect.. I think maybe someone is manipulating our stock huh? Clinical trials going great a EMA drug submission and a Amgen milestone Payment and we're worth $1.50 a share? I'm taking away the cash that's worth $2.50 per diluted share so that's what we're worth right now! ??? $1.50 .... That's why I'm buying as many shares as I can ! We're worth more than a McDouble at McDonalds a share including the ketchup and pickles and two pieces of cheese. Break it down our share price isn't valued at today's price it's being manipulated in a very suspicious way. Not sure who's pulling these strings but my bet is Adage is a shorting machine! Trust no one until the SEC makes the Shorts be public info! Until then they will continue their charade of being "Longterm' investors. No doubt we have a bunch of snakes in our grass slithering around to devour any unsuspecting retail investors. If this goes any lower our cash on hand will be worth more than the shares we hold? Simply saying everything we have is not being valued at all? ZERO is being nice! Do what you want but I'm laughing at the opportunity to buy down here it's a gift that won't come again for a very long time! Once the right news is released this thing is going to fly with or without you! I don't really care if your onboard but I'm still buying down here! Saw this with DNDN and saw it shoot to $60 so don't think it can't happen cause it can and hopefully will. Remember we have a unique platform that's proven to be "SAFE" and very Effective not to mention very affordable for everyone in the world! Our platform will be very hard to push under the rug because as we all know healthcare has become outrageously exspensive . We can treat multiple cancers with our platform that can be mass produced at very efficient cost basis. I think we have a great opportunity to be a leader in the Immunotherapy space in the next couple years. We will get bought out in the next year. Once we submit our drug application to the EMA the tide will change here on our stock and in case it doesn't you better buy all you can because we going to get bought out in 2018! $3.90 a share is a super steal downhere. Good Luck in 2018 because at this time next year we may be already sold! Depends on how quick we get EMA approval. Once that happens we will put on our prettiest Prom dress and let the bidding begin!